Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia

AIM: To assess the efficacy and safety of an intravitreal injection of bevacizumab (Avastin®) for myopic choroidal neovascularisation (mCNV). METHODS: Intravitreal bevacizumab (1 mg) was injected into eight eyes of eight patients with mCNV in this non‐randomised, interventional case series. The best...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sakaguchi, H, Ikuno, Y, Gomi, F, Kamei, M, Sawa, M, Tsujikawa, M, Oshima, Y, Kusaka, S, Tano, Y
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2007
Soggetti:
Clinical Science - Extended Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857602/
https://ncbi.nlm.nih.gov/pubmed/16914470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.099887
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi